%0 Journal Article %A TAKAFUMI KUMAMOTO %A RYUSEI MATSUYAMA %A KAZUHISA TAKEDA %A YU SAWADA %A KOTA SAHARA %A DAISUKE MORIOKA %A SHAO-CIAO LUO %A YASUHIRO YABUSHITA %A YUKI HOMMA %A ITARU ENDO %T Surgical Indications for Huge Hepatocellular Carcinoma %D 2022 %R 10.21873/anticanres.15735 %J Anticancer Research %P 2573-2581 %V 42 %N 5 %X Background/Aim: This study aimed to retrospectively analyse adverse predictors to identify patients with huge hepatocellular carcinoma who were not appropriate candidates for hepatic resection. Patients and Methods: From 551 patients with hepatocellular carcinoma who underwent hepatectomy between 1992 and 2019, 92 were diagnosed with huge hepatocellular carcinoma (diameter >10 cm) and 115 were diagnosed with large hepatocellular carcinoma (diameter=5-10 cm). Clinical features and overall and disease-free survival rates were compared between the two groups. Results: Cumulative overall survival was significantly worse in the huge group than in the large group (p=0.035). In the huge group, multivariate analyses revealed that liver cirrhosis, multiple intrahepatic metastases (≥4), poor histological grade, and macroscopic portal vein invasion were significantly associated with poor prognosis. Conclusion: We identified four adverse predictors of survival and determined that patients with two or more predictors are not appropriate candidates for straightforward hepatic resection. %U https://ar.iiarjournals.org/content/anticanres/42/5/2573.full.pdf